|
Jun 29
|
Catalent's (CTLT) Facility Snag Linked to Regeneron's Eylea CRL
|
|
Jun 29
|
The Zacks Analyst Blog Highlights Texas Instruments, Regeneron Pharmaceuticals, Micron Technology, FedEx and Arista Networks
|
|
Jun 28
|
Why Catalent Stock Flopped Today
|
|
Jun 28
|
Catalent Is Linked to Regeneron’s Eye-Drug Rejection in Latest Misstep
|
|
Jun 28
|
Top Analyst Reports for Texas Instruments, Regeneron & Micron Technology
|
|
Jun 28
|
Regeneron Pharmaceuticals' (NASDAQ:REGN) five-year total shareholder returns outpace the underlying earnings growth
|
|
Jun 28
|
Regeneron (REGN) Gets CRL for Aflibercept 8 mg Drug, Shares Fall
|
|
Jun 27
|
Regeneron Stock Crumbles After FDA Rejects Its Next Blockbuster Contender
|
|
Jun 27
|
Regeneron Stock Slumps After FDA Decision Delays Blockbuster Release
|
|
Jun 27
|
Two-year Results for Aflibercept 8 mg from Pivotal PHOTON Trial Demonstrate Durable Vision Gains at Extended Dosing Intervals in Diabetic Macular Edema
|
|
Jun 27
|
FDA Issues Complete Response Letter (CRL) for Aflibercept 8 mg Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-party Filler
|
|
Jun 27
|
10 Martin Shkreli Stock Picks and Their Performance
|
|
Jun 21
|
2 Biotech Stocks You Can Buy and Hold for the Next Decade
|
|
May 1
|
Is a Beat on the Cards for Regeneron's (REGN) Q1 Earnings?
|
|
Apr 28
|
Stock Charts Strategy, May 1-5: Fed Policy, April Payrolls, Apple Earnings
|
|
Apr 27
|
Regeneron (REGN) Gains But Lags Market: What You Should Know
|
|
Apr 27
|
Alnylam - Regeneron Partnered Alzheimer's Candidate's Initial Data Sounds Promising, Analyst Says
|
|
Apr 27
|
Regeneron (REGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Apr 26
|
Regeneron and Alnylam Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
|
|
Apr 26
|
Alnylam and Regeneron Report Positive Interim Phase 1 Clinical Data on ALN-APP, an Investigational RNAi Therapeutic for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
|